Pearl Avery – Poster presentation at ECCO 2020
New Packaging Format – From May 2020
Original Packaging Format – Pre May 2020
BÜHLMANN presented an Educational Workshop at EuroMedLab 2019 about optimising the
Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.
The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.
Join Our Calprotectin Community! June 8, 2020
Calprotectin is Now Part of the New ECCO & ESGAR Guidelines August 8, 2019
The New Faecal Calprotectin Care Pathway | NICE February 1, 2019